We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

688188:SSEShanghai BOCHU Electronic Technology Corporation Limited Class A Analysis

Data as of 2026-06-22 - not real-time

CN¥154.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Shanghai BOCHU Electronic Technology demonstrates robust profitability, with a 10.5% revenue growth and margins that are among the highest in the sector—gross margin of 76.9%, operating margin of 59.4% and profit margin of 52.2%. The balance sheet is exceptionally strong, boasting 5.5 billion CNY in cash, negligible debt (19.5%. However, the market price of 154 CNY is far above the DCF‑derived fair value of ≈70 CNY, and the current PE of 38× sits at the industry average, suggesting the stock is priced for optimism. Technically, the stock sits below its 20‑day SMA (159.6) while the SMA hierarchy (20 > 50 > 200) remains bullish, MACD is marginally bullish and volume is increasing, but the 30‑day volatility of 47.7% and a recent pull‑back from a previous close of 168.59 CNY indicate short‑term pressure.
Given the strong fundamentals but pronounced overvaluation and elevated volatility, investors should view the stock as a medium‑term hold with a potential upside if the price corrects toward its intrinsic value, while remaining cautious of sector‑specific cycles and regulatory dynamics in China.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below 20‑day SMA indicating near‑term weakness
  • Significant overvaluation relative to DCF fair value
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong earnings growth and margin expansion
  • Improving forward PE (26×) versus trailing PE (38×)
  • Bullish MACD and increasing volume supporting a potential rebound

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Exceptional cash generation and negligible debt
  • High profitability and ROE indicating sustainable competitive advantage
  • Potential valuation correction aligning price with intrinsic value

Key Metrics & Analysis

Financial Health

Revenue Growth10.50%
Profit Margin52.21%
P/E Ratio38.0
ROE19.48%
ROA11.45%
Debt/Equity0.19
P/B Ratio7.0
Op. Cash FlowCN¥1.1B
Free Cash FlowCN¥717.2M
Industry P/E38.1

Technical Analysis

TrendBullish
RSI45.2
SupportCN¥145.87
ResistanceCN¥176.50
MA 20CN¥159.65
MA 50CN¥154.35
MA 200CN¥146.09
MACDBullish
VolumeIncreasing
Fear & Greed Index90.71

Valuation

Fair ValueCN¥69.77
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.13
Volatility47.70%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.